Statistical analysis of the stages of HIV infection using a Markov model.

@article{Longini1989StatisticalAO,
  title={Statistical analysis of the stages of HIV infection using a Markov model.},
  author={Ira M. Longini and Clark Ws and Robert H. Byers and John Wesley Ward and Darrow Ww and Lemp Gf and Herbert W. Hethcote},
  journal={Statistics in medicine},
  year={1989},
  volume={8 7},
  pages={
          831-43
        },
  url={https://api.semanticscholar.org/CorpusID:22917543}
}
One of the most complete statistical descriptions to date of the natural history of HIV infection is presented, using a staged Markov model to estimate the distribution and mean length of the incubation period for acquired immunodeficiency syndrome (AIDS).
View on PubMed
masedki.github.io
305 Citations
Highly Influential Citations
8
Background Citations
43
Methods Citations
32
Results Citations
4

Figures and Tables from this paper

305 Citations

The stages of HIV infection: waiting times and infection transmission probabilities

Stochastic models used to estimate the waiting time distributions for progressive stages of HIV infection and to estimate stage-specific infection transmission probabilities between exposed and infected persons are extended to assess the risk of HIV transmission for different levels of important risk factors.

Estimating the stage-specific numbers of HIV infection using a Markov model and back-calculation.

An extension of back calculation that provides estimates of the numbers of HIV infectives in different stages of infection is presented, using the estimated AIDS incubation period distribution for the Markov model in back calculation from AIDS incidence data to estimate the total number of HIV infections and the parameters of the infection probability distribution.

Using Markov Processes to Describe the Prognosis of HIV-1 Infection

The results indicate that the combination of a severity-of-illness clinical staging system with Markov illness-and-death process modeling is particularly useful for the evaluation of prognostic factors influencing the course of HIV-1 disease progression.

Modeling the Progression of HIV Infection

The ability to discriminate between models can be enhanced by incorporating information about the distributions of the times of seroconversion (development of measurable antibodies) among HIV seropositive ind...

HIV-1 transmission, by stage of infection.

Primary and late-stage HIV-1 infection are more infectious than previously estimated, but for shorter periods.

The effects of population structure on the spread of the HIV infection.

Results show clearly the sensitivity of model outcomes to variation in the patterns of contact among individuals and the need for better data on such interactions to aid in understanding and predicting the spread of HIV.

Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project.

Markov modeling using the revised pediatric HIV classification system allowed us to describe the natural history of HIV disease in children before diagnosis of AIDS, finding that children progress to moderate symptoms in the second year of life and then remain moderately symptomatic for more than half of their expected lives, underscores their need for clinical care before the onset of AIDS.

A dynamical model for stage-specific HIV incidences with application to sub-Saharan Africa

Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa

There is need to monitor adverse reaction to drugs more frequently, screen HIV/AIDS patients for any signs and symptoms of TB and check for factors that may explain gender differences further, including development of TB during the course of treatment.

Modelling the progression of treatment scenarios in the HIV/AIDS epidemic

This thesis establishes a model of the HIV/AIDS epidemic that incorporates the effects of treatments, in particular, the introduction of highly active antiretroviral therapy (HAART), which became widely available during 1996.
...

44 References

Incubation period of AIDS in patients infected via blood transfusion

New analysis of the number of reported cases of AIDS in a defined population to the proportion of that population infected with the virus as a specified time point reveals age-related differences in the mean and median incubation period.

A model-based estimate of the mean incubation period for AIDS in homosexual men.

A model for the proportion likely to develop AIDS and the incubation period for AIDS in homosexual men could be derived and is close to the estimate of 8.2 years for adults developing transfusion-associated AIDS.

A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS.

Preliminary attempts to formulate simple mathematical models of the transmission dynamics of HIV infection in homosexual communities are described, and the influence of variation in the incubation period and heterogeneity in sexual activity is assessed.

Projections of AIDS morbidity and mortality in San Francisco.

The model projects 12,349 to 17,022 cumulative cases of AIDS in San Francisco through June 1993, with 9,966 to 12,767 cumulative deaths, and projected AIDS mortality by applying Kaplan-Meier estimates of survival time following diagnosis to the projected number of cases.

A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome.

The mean incubation period for transfusion-associated AIDS was estimated to be 4.5 years, with the 90% confidence interval ranging from 2.6 to 14.2 years, which has important consequences for infected individuals and implications for public health intervention and prevention policy.

Biases in prevalent cohorts.

The biases inherent in using follow-up time instead of time from infection are investigated for estimation of both the cumulative distribution function and the hazard ratio for proportional hazards models with both fixed and time-dependent covariates.

Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Results indicate that increased HIV gene expression is a contributing factor to the development of AIDS and also provide evidence for a switch from latent to active HIV infection.

Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.

In a cohort of 5833 subjects in whom the acquired immunodeficiency syndrome (AIDS) was diagnosed in New York City before 1986, the cumulative probability of survival was 48.8 +/- 0.7 percent at one year and 15.2 +/- 1.8 percent at five years; the range in the mortality rate was greater than threefold, depending on these variables.

The prevalent cohort study and the acquired immunodeficiency syndrome.

Risks derived from a prevalent cohort are not directly comparable to risk estimates derived from an incident cohort, because the time of viral infection is usually unknown in the cohort.

ANTIBODY RESPONSE IN PRIMARY HUMAN IMMUNODEFICIENCY VIRUS INFECTION